Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sue Lightman

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Case Reports in Ophthalmology|January 1, 2013
Combined infliximab and rituximab in necrotising scleritisJiten Morarji, Lavnish Joshi, Oren Tomkins-Netzer, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 7, 2016
Difference in glaucoma progression between the first and second eye after consecutive bilateral glaucoma surgery in patients with bilateral uveitic glaucomaNorshamsiah Md Din, Lazha Talat, Hazlita Isa, et al.
American Journal of Ophthalmology|August 30, 2011
Behçet disease: visual prognosis and factors influencing the development of visual lossSimon R J Taylor, Jasmin Singh, Victor Menezo, et al.
American Journal of Ophthalmology|April 1, 2018
Effect of Antituberculous Therapy on Uveitis Associated With Latent TuberculosisOren Tomkins-Netzer, Belinda C S Leong, Xiaozhe Zhang, et al.
Progress in Retinal and Eye Research|May 28, 2015
Functional outcome of macular edema in different retinal disordersOren Tomkins-Netzer, Filis Ismetova, Asaf Bar, et al.
Journal of Neuroinflammation|February 19, 2021
Small-molecule antagonist of VLA-4 (GW559090) attenuated neuro-inflammation by targeting Th17 cell trafficking across the blood-retinal barrier in experimental autoimmune uveitisYi Hsing Chen, Malihe Eskandarpour, Xiaozhe Zhang, et al.
Ophthalmology|November 6, 2012
Dexamethasone implant in pediatric uveitisSimon R J Taylor, Oren Tomkins-Netzer, Lavnish Joshi, et al.
Ophthalmology|October 15, 2019
Long-Term Outcomes of Treatment with Biological Agents in Eyes with Refractory, Active, Noninfectious Intermediate Uveitis, Posterior Uveitis, or PanuveitisAhmed Al-Janabi, Amgad El Nokrashy, Lazha Sharief, et al.
International Immunology|May 7, 2026
Selective decreases in regulatory B cell (Breg) subsets in active uveitis: IL-10+CD19+CD24hiCD38hiBreg in patients and B10 Breg in miceYi-Hsing Chen, Xiaozhe Zhang, Malihe Eskandarpour, et al.
European Journal of Ophthalmology|December 25, 2012
Intravitreal triamcinolone acetonide as adjunctive treatment with systemic therapy for uveitic macular edemaZohar Habot-Wilner, Ahmed Sallam, Patricio A Pacheco, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Case Reports in Ophthalmology|January 1, 2013
Combined infliximab and rituximab in necrotising scleritisJiten Morarji, Lavnish Joshi, Oren Tomkins-Netzer, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 7, 2016
Difference in glaucoma progression between the first and second eye after consecutive bilateral glaucoma surgery in patients with bilateral uveitic glaucomaNorshamsiah Md Din, Lazha Talat, Hazlita Isa, et al.
American Journal of Ophthalmology|August 30, 2011
Behçet disease: visual prognosis and factors influencing the development of visual lossSimon R J Taylor, Jasmin Singh, Victor Menezo, et al.
American Journal of Ophthalmology|April 1, 2018
Effect of Antituberculous Therapy on Uveitis Associated With Latent TuberculosisOren Tomkins-Netzer, Belinda C S Leong, Xiaozhe Zhang, et al.
Progress in Retinal and Eye Research|May 28, 2015
Functional outcome of macular edema in different retinal disordersOren Tomkins-Netzer, Filis Ismetova, Asaf Bar, et al.
Journal of Neuroinflammation|February 19, 2021
Small-molecule antagonist of VLA-4 (GW559090) attenuated neuro-inflammation by targeting Th17 cell trafficking across the blood-retinal barrier in experimental autoimmune uveitisYi Hsing Chen, Malihe Eskandarpour, Xiaozhe Zhang, et al.
Ophthalmology|November 6, 2012
Dexamethasone implant in pediatric uveitisSimon R J Taylor, Oren Tomkins-Netzer, Lavnish Joshi, et al.
Ophthalmology|October 15, 2019
Long-Term Outcomes of Treatment with Biological Agents in Eyes with Refractory, Active, Noninfectious Intermediate Uveitis, Posterior Uveitis, or PanuveitisAhmed Al-Janabi, Amgad El Nokrashy, Lazha Sharief, et al.
International Immunology|May 7, 2026
Selective decreases in regulatory B cell (Breg) subsets in active uveitis: IL-10+CD19+CD24hiCD38hiBreg in patients and B10 Breg in miceYi-Hsing Chen, Xiaozhe Zhang, Malihe Eskandarpour, et al.
European Journal of Ophthalmology|December 25, 2012
Intravitreal triamcinolone acetonide as adjunctive treatment with systemic therapy for uveitic macular edemaZohar Habot-Wilner, Ahmed Sallam, Patricio A Pacheco, et al.
Pageof 10